# The application value and limitations of metagenomic detection technology based on cerebrospinal fluid samples in suspected central nervous system infection: a retrospective study

**Authors:** Qiujuan Feng, Baoyi Liu, Huazhao Liu, Yaqin Fan, Shanshan Gao, Jia Zhang, Yingjie Kuang, Wenshan Wang, Huiqiang Liang, Yulan Qiu, Huamei Wen, Zize Feng, Yanming Huang, Wanli Zuo, Xin Zhang, Jincheng Zeng, Jinhua Wu, Yuanhao Liang, Jiyong Gu

PMC · DOI: 10.3389/fmicb.2025.1689253 · Frontiers in Microbiology · 2026-01-07

## TL;DR

This study shows that metagenomic sequencing of cerebrospinal fluid helps diagnose central nervous system infections better than traditional methods, though it has some limitations.

## Contribution

The study provides empirical evidence on the diagnostic performance and limitations of mNGS in CNS infections using a large retrospective cohort.

## Key findings

- mNGS outperformed culture and conventional methods in diagnosing CNS infections.
- False negatives in mNGS were mainly due to missed viral detection.
- Certain pathogens detected by mNGS, like Epstein–Barr virus, showed high pathogenic potential.

## Abstract

Accurately diagnosing central nervous system (CNS) infections remains challenging. This study aimed to evaluate the effectiveness of metagenomic next-generation sequencing (mNGS) in diagnosing suspected CNS infections and its role in facilitating rapid and accurate pathogen identification.

This retrospective study enrolled cerebrospinal fluid specimens from 246 patients with suspected CNS infections and 20 controls with definitively ruled-out infections. Using clinical diagnoses established by an expert panel based on comprehensive criteria as the reference standard, we evaluated the diagnostic performance of mNGS relative to culture and conventional tests. Additionally, we analyzed the therapeutic guidance value of positive mNGS results and risk factors for false negatives.

mNGS showed 73.2% (180/246) agreement with clinical diagnosis, superior to culture (54.1%, 133/246) and conventional methods (61.4%, 151/246). For general bacteria and fungi, mNGS showed 61.9% (26/42) concordance with culture. False negatives in mNGS predominantly involved viral missed detection. Age, presence of systemic infection, headache, and cerebrospinal fluid glucose levels were likely key determinants of mNGS performance. mNGS detection of Epstein–Barr virus, Streptococcus spp., Mycobacterium tuberculosis complex, herpes simplex virus type 1, and Staphylococcus spp. suggested high pathogenic potential, whereas Torque teno virus detection more likely indicated carriage or experimental contamination.

mNGS holds significant value for the diagnosis, therapeutic management, and prognostic assessment of suspected CNS infections.

## Linked entities

- **Species:** Mycobacterium tuberculosis complex (taxon 77643), Torque teno virus (taxon 68887)

## Full-text entities

- **Diseases:** headache (MESH:D006261), infection (MESH:D007239), CNS infections (MESH:D002494)
- **Chemicals:** glucose (MESH:D005947)
- **Species:** Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Homo sapiens (human, species) [taxon 9606], Fungi (kingdom) [taxon 4751], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Mycobacterium tuberculosis complex (species group) [taxon 77643], Torque teno virus (species) [taxon 68887]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12819739/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12819739/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12819739/full.md

---
Source: https://tomesphere.com/paper/PMC12819739